Insider · CIK 0001567282
Dean Janeway
Files at MAMA (Mama's Creations, Inc.). First filing -, latest -.
In brief
Dean Janeway files SEC Form 4 as director at MAMA (Mama's Creations, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dean Janeway has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | MAMA Mama's Creations, Inc. | AGrant or award Common Stock | +2,200 | $0.00 | $0 | 347,419 | Jul 8, 2026 |
| Jul 7, 2025 | MAMA Mama's Creations, Inc. | AGrant or award Common Stock | +4,500 | - | - | 345,219 | Jul 9, 2025 |
| Jul 3, 2024 | MAMA Mama's Creations, Inc. | AGrant or award Common Stock | +5,340 | - | - | 340,719 | Jul 8, 2024 |
| May 15, 2024 | MAMA Mama's Creations, Inc. | JOther Common Stock | +16,918 | - | - | 335,379 | May 17, 2024 |
| Oct 18, 2023 | MAMA Mama's Creations, Inc. | AGrant or award Common Stock | +11,299 | - | - | 354,760 | Oct 20, 2023 |
Questions about Dean Janeway
Answered from the filings on this page, as of the latest one.
Is Dean Janeway buying or selling?
Dean Janeway has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dean Janeway's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dean Janeway has 0.
Where does Dean Janeway file Form 4?
Dean Janeway has filed Form 4 at MAMA (Mama's Creations, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.